Philips CPAP Recall Lawsuit Attorneys

Philips CPAP Recall Lawsuit Attorneys

Philips Respironics has issued a recall for some of its CPAP, BiPAP, and mechanical ventilator devices after potential health risks related to lung injury have been identified. People or loved ones of those who were injured due to a Philips Respironics Bi-Level Positive Airway Pressure (BiPAP) or Continuous Positive Airway Pressure (CPAP) may be eligible for compensation through a Philips CPAP Recall Lawsuit.

Open, accepting new clients
Free Consultation - No Obligation

Complete this form and we’ll get in touch within 24 hours

All required fields are marked with an asterisk "*"
Name(Required)
State(Required)

By submitting this form I agree to the terms of SeegerWeiss.com Terms & Conditions and Privacy Policy.

This field is for validation purposes and should be left unchanged.

Our Role

Seeger Weiss founding partner Chris Seeger was appointed as co-lead counsel by Senior U.S. District Court Judge Joy Flowers Conti in litigation related to the use of Philips CPAP sleep apnea machines and other Philips assisted breathing devices. Seeger Weiss was one of the first law firms to file a lawsuit against Philips regarding the disintegration or outgassing of the foam in these ventilator devices and has since filed more than a dozen cases while representing more than 2,500 people seeking to hold Philips accountable.

Case Updates

  • 9/7/23

    Seeger Weiss founding partner Chris Seeger, who serves as co-lead counsel in the Philips Recalled CPAP, Bi-PAP, and Mechanical Ventilator Litigation, announced an uncapped settlement worth a minimum of $479M to resolve economic loss claims of users and payers impacted by the recall. Seeger Weiss will continue to pursue personal injury and medical monitoring claims on behalf of its clients.

  • 2/16/23

    As of February 16, 2023, two class action complaints and more than 420 individual lawsuits alleging physical injury have been filed in In Re: Philips Recalled CPAP, Bi-Level PAP, and Mechanical Ventilator Products Liability Litigation.

  • 11/15/22

    The New York Times reported the United States Department of Justice is negotiating a consent decree with Philips related to its conduct surrounding the recall.

  • 8/22/22

    Attorneys representing plaintiffs filed a class action complaint for medical monitoring and a master personal injury complaint. Plaintiffs are seeking to have Philips cover the cost of medical monitoring for patients who used the recalled devices. In addition, those with injuries allegedly caused by Philips’ recalled devices now have a set of common facts and claims for suing the company.

  • 6/17/22

    Attorneys representing plaintiffs filed a class action complaint for economic losses. The complaint alleges Philips knew of PE-PUR foam degradation issues with the recalled for years but continued to sell these devices and advertise them as safe while doing nothing to fix the problem. Plaintiffs allege the company failed to disclose the dangerous defect in its devices or remove them from the market until it initiated the recall in June 2021. The complaint seeks Plaintiffs to recover economic losses and punitive damages from Philips.

  • 5/27/22

    Email correspondence between Philips and a supplier about foam degradation was filed on the court docket. The documents show Philips knew about foam degradation issues with the recalled devices no later than 2015, but did not recall affected products until 2021.

  • 5/2/22

    The FDA issued a 518(b) notice, proposing a requirement for Philip to submit a plan for the repair, replacement, or refund of the purchase price of the recalled devices. In the notice, the FDA said there is sufficient evidence to determine “that the risk associated with the devices was not caused by the failure of a person other than Philips to exercise due care in the installation, maintenance, repair, or use of the devices at issue.”

  • 3/10/22

    The FDA issued a 518(a) notification order to Philips because of the company’s “failure to timely provide effective notice” of the recall. Philips was ordered to notify people of the “unreasonable risk of substantial harm to the public health” posed by the foam degradation within 45 days.

  • 2/16/22

    Senior U.S. District Court Judge Joy Flowers Conti appointed Seeger Weiss LLP founder Chris Seeger to serve as co-lead counsel in the Philips Recalled CPAP, Bi-Level PAP, and Mechanical Ventilator Products Liability Litigation. Seeger is one of four attorneys, selected from a pool of 75 applicants, to lead the litigation. He has led some of the most complex, groundbreaking, and high-profile litigations in U.S. history, including National Prescription Opioid Litigation, 3M Combat Arms Earplug Products Liability Litigation, and National Football League Players’ Concussion Injury Litigation.

  • 11/9/21

    The FDA released an inspection report of Philips’ Murrysville, Pennsylvania manufacturing facility. The report concluded that Philips knew about the foam degradation issues since 2015, but failed to properly conduct a health hazard evaluation, a risk analysis, or a design review prior to the recall.

  • 10/11/21

    The Judicial Panel on Multidistrict Litigation (JPML) granted a motion to consolidate lawsuits against medical device manufacturer Philips over its CPAP, Bi-Level PAP and mechanical ventilator recall before Senior U.S. District Judge Joy Flowers Conti in the Western District of Pennsylvania. Centralization will help streamline the process of discovery and key legal motions before trials.

  • 8/27/21

    Seeger Weiss filed a class action lawsuit on behalf of Edward Haddix and other similarly situated assisted breathing machine users against Philips. The complaint alleged that Philips designed, manufactured, marketed, advertised, distributed, and sold dangerously defective apnea and breathing devices to consumers nationwide, despite knowing that the foam in these devices could disintegrate or outgas, resulting in serious injuries.

  • 6/14/21

    Philips issued a recall for its Continuous Positive Airway Pressure (CPAP), Bi-Level Positive Airway Pressure (Bi-Level PAP), and mechanical ventilator devices over serious health risks caused by foam liners used in the design and manufacture of the recalled products. The company admitted that the foam may disintegrate or outgas, resulting in inhalation of toxic contaminants and chemicals, which may increase the chance of lung injury and may also increase the risk of cancer. The U.S. Food and Drug Administration Class I recall indicates the products have the potential to cause “serious adverse health consequences or death.”